Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102178Source: DataRank Database

Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy is a research paper published in Molecular Therapy — Nucleic Acids (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

omim doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 3.92)OA: goldTopics (27)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Apurva Sarathy ORCID,Véronique Bolduc ORCID,Grace S. Chen,Riley M. McCarty,Carsten G. Bönnemann ORCID

Live enrichment

PubMed:38617974 PMC:PMC11015156 OpenAlex:https://openalex.org/W4393165581

Intramural NIH HHS

Grant: ZIA NS003129

National Institutes of Health

Grant: 1ZIANS003129-06

Molecular and Clinical Manifestations of Matrix and Aggregate Myopathies

Cure CMD

National Institute of Neurological Disorders and Stroke

FWCI

3.92

Citation Percentile

0.9%

Citation Trend

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.omtn.2024.102178

publisherhttps://doi.org/10.1016/j.omtn.2024.102178

publisherhttps://api.elsevier.com/content/article/PII:S2162253124000659?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2162253124000659?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38617974

Fields of Study

Cell Adhesion Molecules ResearchRNA Interference and Gene DeliveryMuscle Physiology and Disorders0301 basic medicine0303 health sciences03 medical and health sciences

Keywords

Collagen VIMuscular dystrophyGeneticsAlleleCongenital muscular dystrophySubstitution (logic)MedicineBiologyExtracellular matrixGeneComputer scienceSiRNAMissense mutationDominant NegativeCollagen Type ViAllele-specific SilencingUllrich Congenital Muscular DystrophyMt: Oligonucleotides: Therapies And ApplicationsOriginal ArticleTherapeutics. PharmacologyRM1-950

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Zero hunger

Optimized allele-specific silencing of the dominant-negative COL6A1 G293R substitution causing collagen VI-related dystrophy

FAIR Checklist

Authors (6)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)